CLYM vs CRMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

CLYM

48.1
AI Score
VS
CLYM Wins

CRMD

44.9
AI Score

Investment Advisor Scores

CLYM

48score
Recommendation
HOLD

CRMD

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CLYM CRMD Winner
Net Income -27.22M 163.06M CRMD
Operating Income -30.57M 150.14M CRMD
ROE -11.4% 40.2% CRMD
ROA -11.1% 19.7% CRMD
Total Assets 246.29M 826.14M CRMD
Cash 44.11M 144.84M CRMD
Current Ratio 31.45 2.11 CLYM
Free Cash Flow -25.18M 172.79M CRMD

Relative Price Performance (Last 90 Days)

CLYM 1M: -14.3% · 3M: -20.3% CRMD 1M: +1.0% · 3M: +3.3%

Current Technical Phase

CLYM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.1%), weak momentum, RSI 38

RSI (14): 38.2 · Price: $10.19

CRMD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 55.7 · Price: $7.85

Fundamentals Snapshot

Metric CLYM CRMD
Market Cap — —
Forward P/E -10.2 138.5
Trailing P/E — 3.8
Revenue (TTM) — —
Revenue Growth 0.0% 1.6%
Gross Margin — 0.9%
Operating Margin 0.0% 0.4%
EPS -0.80 2.13
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.